Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imipramine and Photodynamic Therapy for Actinic Keratosis
NCT05688904Phase 1Recruiting
- Sponsor
- Wright State University
- Start
- Jan 2023
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in actinic keratosis (AK) comparing Imipramine with Vehicle (2 arms). Primary endpoint: Number of precancerous actinic keratosis present at 6 months. Started Jan 2023; status: recruiting.
02
Drugs
imipramine
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT05688904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05688904.